40 Live Notices for Naloxone Tenders
Showing 1 to 20
"Delivery Of Medicinal Products For The Needs Of Clinics And Compartments Of Usbalo" Prof. Ivan Chernozemski "Ead, In Lots - Part 2"
13 Mar 2025
23 Apr 2025Medications
Injections
Sda Farmaci N.03/2025
Essential Medicines
Object: Electronic Auction - Acquisition Of Pentoxifiline 400 Mg Coated Tablet, Nifedipine 20Mg Delayed Liberation Tablet, Norfloxacin 400 Mg Compressed Nitropuranto, Olanzapine 10 Mg Compressed Morphine 10Mg/Ml Solution 1Ml Ampolo 1Ml.
* Price Registration * Pentoxifiline Acquisition 400 Mg Coated Tablet, Nifedipine 20Mg Delayed Release Tablet, Norfloxacin 400 Mg Compressed, Nitrofurantoin 100 Mg Compressed, Olanzapine 10 Mg Compressed, Morphine 10Mg/Ml Solution 1Ml Ampoule. Naloxone
Object: Electronic Auction - Acquisition Of Free Distribution Medicines - Basic Pharmacy, Pams And Consumption.
Object: Electronic Auction - Price Registration For The Acquisition Of Medicines For The Municipal Health Foundation Of Foz Do Iguaçu -Pr During The 12 -Month Period.
6D012-247322 - Vendor Managed - 3 Streams
10 NALOXONE HCL INJ: 0.4 MG/ML, 1 ML AMP MAPIN AM 10
Delivery Of Medicinal Products For The Needs Of Medical Institute - Ministry Of Interior For A Period Of Three Years
Medicinal Preparations (13 Medicines, Open Contest) Iii
Supply of Medicine and Medical / Surgical equipments : Naloxone Injection 400microgram/1ml Ampoule\nNaloxone Injection BP,400mcg/1ml\nOR\nNaloxone Hydrochloride Injection USP,\n400mcg/1ml Each 1ml amber coloured ampoule to\ncontain Naloxone Hydrochloride BP/USP\nequivalent to 400mcg of anhydrous Naloxone\nHydrochloride for subcutaneous, intramuscular and\nintravenous use.\n1.The Injection should be stable for minimum of 24\nmonths when stored at a temperature range of\n28'C-32'C\n2.Each ampoule should be labelled accordingly.\nPacking : 10 Ampoules in a Pack etc .
6D012-247322 - Vendor Managed - 3 Streams
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Oxycodone/Naloxone (Atc Code According To Who: N02Aa55)
Tenders by Country